LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.75
EUR
0.10
EUR
2.62 %
22.09.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 4.20 USD | 0.00 USD | 0.10 % |
|---|
| Vortag | 4.20 USD | Datum | 18.09.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 191.37% | |
| 21Shares Uniswap ETP | CH1135202096 | 182.45% | |
| 21shares Ethena ETP | CH1506167035 | 136.28% | |
| 21Shares Aave ETP | CH1135202120 | 95.46% | |
| 21Shares Pendle ETP | CH1495416997 | 83.27% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 82.27% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 68.63% | |
| 21Shares Maple Finance ETP | CH1495416989 | 66.77% | |
| 21Shares Injective Staking ETP | CH1360612134 | 49.76% | |
| 21Shares Jupiter ETP | CH1480821383 | 40.16% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 210.11% | |
| 21Shares Raydium ETP | CH1480821391 | 186.04% | |
| 21Shares Injective Staking ETP | CH1360612134 | 150.59% | |
| 21Shares Uniswap ETP | CH1135202096 | 146.22% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 135.97% | |
| 21shares Ethena ETP | CH1506167035 | 114.82% | |
| 21Shares Pendle ETP | CH1495416997 | 106.99% | |
| 21Shares Jupiter ETP | CH1480821383 | 65.04% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 35.69% | |
| 21Shares Sui Staking ETP | CH1360612159 | 7.09% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 64.52% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 39.52% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 6.51% | |
| 21Shares Uniswap ETP | CH1135202096 | -6.41% | |
| 21Shares Binance BNB ETP | CH0496454155 | -21.00% | |
| 21Shares Injective Staking ETP | CH1360612134 | -45.73% | |
| 21shares XDC Network Staking ETP | CH1464217285 | -62.63% | |
| 21Shares Dogecoin ETP | CH1431521033 | -65.64% | |
| 21Shares Sui Staking ETP | CH1360612159 | -72.27% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -72.27% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 144.96% | |
| 21Shares Stellar ETP | CH1109575535 | 107.65% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 71.94% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 63.54% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 35.42% | |
| 21Shares Sui Staking ETP | CH1360612159 | -31.17% | |
| 21Shares Injective Staking ETP | CH1360612134 | -63.89% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 1’024’146.18 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 22.09.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 95.71 | |
| Performance 2 Jahre | 94.82 | |
| Performance 3 Jahre | 67.20 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |